BRAF and cancer: The dependence of these papillary thyroid cancer cells on signaling through the MAPK pathway and the resulting profound anti-cancer effects by BRAF inhibition can be characterized as “oncogene addiction” [34] and validate targeting the BRAFV600E mutated protein in thyroid cancer cells.